Dietary fiber is a reliable and apparent element of treatment for patients with type 2 diabetes mellitus and cardiovascular diseases: an easy solution to a complicated problem

Cardiovascular diseases are a frequent comorbid condition in patients with type 2 diabetes mellitus (t2DM). This problem tends to remain acute because of the progression of t2DM, which increases the chances of cardiovascular events. Medicine today has a range of innovative hypoglycemic drugs, which proved their safety and effectiveness towards diseases of cardiovascular system. However, high cardiovascular mortality demonstrates that the medication is not enough effective. Partly lack of success may be explained by not enough work with unmodified risk factors, such as physical activity, smoking and excessive and wrong nutrition. Studies about dietary fiber (DF) let us discuss their including in the dietary plan of patients with t2DM and cardiovascular diseases. One of the promising DF types is Cyamopsis tetragonoloba extract. It showed its effectiveness concerning carbohydrate metabolism and lipid profile, improving, metabolic features of t2DM patients and lowering the risks of cardiovascular events. What is more, the advantage of Cyamopsis tetragonoloba extract is easy to use and has no side effects.

1. Virani S., Alonso A., Aparicio H., Benjamin E., Bittencourt M., Callaway C. et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254–e743. https://doi.org/10.1161/CIR.0000000000000950.

2. Wang X., Li Y., Fan H. The associations between screen time-based sedentary behavior and depression: a systematic review and meta-analysis. BMC Public Health. 2019;19(1):1524. https://doi.org/10.1186/s12889-019-7904-9.

3. Lavie C., Ozemek C, Carbone S., Katzmarzyk P., Blair S. Sedentary Behavior, Exercise, and Cardiovascular Health. Circ Res. 2019;124(5):799–815. https://doi.org/10.1161/CIRCRESAHA.118.312669.

4. Tilg H., Moschen A. Microbiota and diabetes: An evolving relationship. Gut. 2014;63(9):1513–1521. https://doi.org/10.1136/gutjnl-2014-306928.

5. Zhang L., Du J., Yano N., Wang H., Zhao Y., Dubielecka P. et al. Sodium Butyrate Protects-Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice. J Cell Biochem. 2017;118(8):2395–2408. https://doi.org/10.1002/jcb.25902.

6. Ardatskaya M.D. Role of dietary fiber in correcting microbiota disorders and maintaining immunity. RMJ. 2020;(12):24–29. (In Russ.) Available at: https://www.rmj.ru/articles/gastroenterologiya/Roly_pischevyh_volokon_v_ korrekcii_narusheniy_mikrobioty_i_podderghanii_immuniteta.

7. Silva Y., Bernardi A., Frozza R. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. https://doi.org/10.3389/fendo.2020.00025.

8. Ardatskaya M.D. Probiotics, prebiotics and metabiotics in the management of microecological bowel disorders. Meditsinskiy Sovet. 2015;(13):94–99. (In Russ.) Available at: https://www.med-sovet.pro/jour/article/view/343.

9. Ellis P., Wang Q., Rayment P., Ren Y., Ross-Murphy S. Guar gum: agricultural and botanical aspects, physiochemical and nutritional properties, and its use in the development of functional foods. In: Cho S., Dreher M. (eds.). Handbook of dietary fiber. New York: Marcel Dekker; 2001, p. 613. Available at: https://www.taylorfrancis.com/chapters/edit/10.1201/9780203904220-36/guar-gum-peterrory-ellis-qi-wang-phillippa-rayment-yilong-ren-simon-ross-murphy.

10. Greenberg N., Sellman D. Partially hydrolyzed guar gum as a source of fiber. Cereal Foods World. 1998;43(9):703–707. Available at: https://agris.fao.org/agris-search/search.do?recordID=US1997084241.

11. Yoon S., Chu D., Raj Juneja L. Chemical and physical properties, safety and application of partially hydrolized guar gum as dietary fiber. J Clin Biochem Nutr. 2008;42(1):1–7. https://doi.org/10.3164/jcbn.2008001.

12. Yamada K., Tokunaga Y., Ikeda A., Ohkura K., Kaku-Ohkura S., Mamiya S. et al. Effect of dietary fiber on the lipid metabolism and immune function of aged Sprague-Dawley rats. Biosci Biotechnol Biochem. 2003;67(2):429–433. https://doi.org/10.1271/bbb.67.429.

13. Maenaka T., Yokawa T., Ishihara N., Okubo T., Chu D., Nishigaki E. et al. Effects of partially hydrolyzed guar gum on postprandial blood glucose level and disaccharidase. J Jpn Soc Med Use Func Foods. 2007;(4):195–201.

14. Gu Y., Yamashita T., Suzuki I., Juneja L., Yokawa T. Effect of enzyme hydrolyzed guar gum on the elevation of blood glucose levels after meal. Med Biol. 2003;142:19–24. Available at: https://www.researchgate.net/publication/304034095_Effect_of_enzyme_hydrolyzed_guar_gum_on_the_elevation_of_blood_glucose_levels_after_meal.

15. Golay A., Schneider H., Bloise D., Vadas L., Assal J. The effect of a liquid supplement containing guar gum and fructose on glucose tolerance in non–insulindependent diabetic patients. Nutr Metab Cardiovasc Dis. 1995;(5):141–148.

16. Takahashi T., Yokawa T., Ishihara N., Okubo T., Chu D.C., Nishigaki E. et al. Hydrolyzed guar gum decreases postprandial blood glucose and glucose absorption in the rat small intestine. Nutr Res. 2009;29(6):419–425. https://doi.org/10.1016/j.nutres.2009.05.013.

17. Dall’Alba V., Silva F., Antonio J., Steemburgo T., Royer C., Almeida J. et al. Improvement of the metabolic syndrome profile by soluble fibre – guar gum – In patients with type 2 diabetes: a randomised clinical trial. Br J Nutr. 2013;110(9):1601–1610. https://doi.org/10.1017/S0007114513001025.

18. Aro A., Uusitupa M., Voutilainen E., Hersio K., Korhonen T., Siitonen O. Improved diabetic control and hypocholesterolaemic effect induced by longterm dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia. 1981;21(1):29–33. https://doi.org/10.1007/BF03216219.

19. Velázquez M., Davies C., Marett R., Slavin J., Feirtag J. Effect of oligossaccharides and fibre substitutes on short-chain fatty acid production by human faecal microflora. Anaerobe. 2000;6(2):87–92. https://doi.org/10.1006/anae.1999.0318.

20. Hu S., Kuwabara R., de Haan B., Smink A., de Vos P. Acetate and Butyrate Improve β-cell Metabolism and Mitochondrial Respiration under Oxidative Stress. Int J Mol Sci. 2020;21(4):1542. https://doi.org/10.3390/ijms21041542.

21. Gao Z., Yin J., Zhang J., Ward R., Martin R., Lefevre M., Cefalu W. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58(7):1509–1517 https://doi.org/10.2337/db08-1637.

22. Yokozawa T., Nakagawa T., Oya T., Okubo T., Juneja L. Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy. J Pharm Pharmacol. 2009;57(6):773–780. https://doi.org/10.1211/0022357056154.

23. Simon L.A., Gayst S., Balasubramaniam S., Ruys J. Long-term treatment of hypercholesterolaemia with a new palatable formulation of guar gum. Atherosclerosis. 1982;45(1):101–108. https://doi.org/10.1016/0021-9150(82)90175-7.

24. Minekus M., Jelier M., Xiao J., Kondo S., Iwatsuki K., Kokubo S. et al. Effect of Partially Hydrolyzed Guar Gum (PHGG) on the Bioaccessibility of Fat and Cholesterol. Biosci Biotechnol Biochem. 2005;69(5):932–938. https://doi.org/10.1271/bbb.69.932.

25. Landin K., Holm G., Tengborn L., Smith U. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr. 1992;56(6):1061–1065. https://doi.org/10.1093/ajcn/56.6.1061.

26. Hara H., Nagata M., Ohta A., Kasai T. Increases in calcium absorption with ingestion of soluble dietary fibre, guargum hydrolysate, depend on the caecum in partially nephrectomized and normal rats. Br J Nutr. 1996;76(5):773–784. https://doi.org/10.1079/bjn19960083.

27. De Vadder F., Kovatcheva-Datchary P., Zitoun C., Duchampt A., Backhed F., Mithieux G. Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis. Cell Metab. 2016;24(1):151–157. https://doi.org/10.1016/j.cmet.2016.06.013.

28. Jiamiao H., Shaoling L., Baodong Z., Cheung P. Short-chain fatty acids in control of energy metabolism. Crit Rev Food Sci Nutr. 2017;58(8):1243–1249. https://doi.org/10.1080/10408398.2016.1245650.

29. Verhaar B., Prodan A., Nieuwdorp M., Muller M. Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients. 2020;12(10):2982. https://doi.org/10.3390/nu12102982.